A Phase 1/2a Trial to Evaluate the Efficacy and the Safety of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)

Trial Profile

A Phase 1/2a Trial to Evaluate the Efficacy and the Safety of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)

Completed
Phase of Trial: Phase I/II

Latest Information Update: 20 Apr 2016

At a glance

  • Drugs Human papillomavirus vaccine (Primary)
  • Indications Cervical intraepithelial neoplasia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Bioleaders Corporation
  • Most Recent Events

    • 18 Apr 2016 Status changed from recruiting to completed.
    • 12 Jan 2016 Planned End Date changed from 1 Mar 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
    • 12 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Mar 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top